| Vol. 12.33 – 11 September, 2020 |
| |
|
|
| Using murine lineage-tracing models and gene expression profiling, scientists revealed that myeloid cells present in the intima of the aortic arch were not dendritc cells but instead specialized aortic intima resident macrophages that depended upon colony-stimulating factor 1 and are sustained by local proliferation. [Nature Immunology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers demonstrated that the epigenetic regulator Uhrf1 was essential for maintenance of methyl-DNA marks that stabilized Treg cellular identity by repressing effector T cell transcriptional programs. [Journal of Clinical Investigation] |
|
|
|
| Investigators describe a viable hypomorphic allele of dnmt1 in zebrafish that caused widespread demethylation of CpG dinucleotides in sperm and somatic tissues. [Nature Communications] |
|
|
|
| The authors demonstrated that the metastasis-modulating effects of neutrophils were dictated by the status of host NK cells. [Nature Communications] |
|
|
|
| Scientists evaluated the pharmacological potential of glutamine synthetase (GS) inhibitors in targeting metastasis, identifying glufosinate as a specific human GS inhibitor. [EMBO Molecular Medicine] |
|
|
|
| Investigators showed that NR4A3-deficient murine CD8+ T cells differentiated preferentially into memory precursor and central memory cells, but also produced more cytokines. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Scientists manipulated a major mechanism of glial intercellular communication that required connexin-43 and assessed the effects on acute and chronic inflammation, visceral hypersensitivity, and immune responses. [Cell Reports] |
|
|
|
| In an experimental mouse model of crescentic glomerulonephritis induced by an anti-glomerular basement membrane antibody, Tregs started to accumulate in the kidney on day ten of disease onset and remained at high levels during the late stage, which correlated with stable disease control. [Cellular & Molecular Immunology] |
|
|
|
| The authors investigated the anticancer effects of CC1007 in breakpoint cluster region-Abelson 1 fusion gene-negative (BCR-ABL1−) pre-B cell acute lymphoblastic leukemia (B-ALL) cell lines and primary patient-derived BCR-ABL1− pre-B-ALL cells. [Cell Death & Disease] |
|
|
|
| Researchers introduced the human skin and immune system-humanized NOD-scid IL2Rγnull mouse and Sprague–Dawley-Rag2tm2hera Il2rγtm1hera rat models, co-engrafted with human full-thickness fetal skin, autologous fetal lymphoid tissues, and autologous fetal liver-derived hematopoietic stem cells. [Scientific Reports] |
| |
|
|
|
| Investigators discuss genetic models of mouse dendritic cells (DCs) development and function that have aided in correlating ontogeny with function, as well as how these findings can be translated to human DCs and their progenitors. [Nature Reviews Immunology] |
|
|
|
| The effects of pectin include strengthening the mucus layer, enhancing epithelial integrity, and activating or inhibiting dendritic cell and macrophage responses. [Experimental and Molecular Medicine] |
|
|
|
| The authors summarize current knowledge of innate lymphoid cell (ILC) phenotypes in various tissues in mice and humans, aiming to clarify ILC immunity in distinct anatomical locations. [Trends in Immunology] |
|
|
|
|
| Atara Biotherapeutics, Inc. announced the presentation of data from the first part of the ongoing Phase I study of ATA188 for the treatment of progressive forms of multiple sclerosis. [Atara Biotherapeutics, Inc.] |
|
|
|
| Arcutis Biotherapeutics, Inc. announced plans to advance its program to develop ARQ-151 for the treatment of atopic dermatitis into Phase III clinical trials following its End-of-Phase II meeting with the FDA, without conducting the previously planned Phase IIb atopic dermatitis trial. [Arcutis Biotherapeutics, Inc.] |
|
|
|
| The Cancer Research Institute announced the 2020 recipients of its highest scientific and philanthropic awards. CRI will present the awards to seven honorees during its annual gala, Innovators in Science and Philanthropy, which CRI is hosting virtually for the first time. [Cancer Research Institute ] |
|
|
|
|
| June 10-11, 2021 London, England, United Kingdom |
|
|
|
|
|
| Texas Biomedical Research Institute – San Antonio, Texas, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| STEMCELL Technologies – Flexible |
|
|
|
| University Hospital Erlangen – Erlagen, Germany |
|
|
|
| Cedars-Sinai Hospital – Los Angeles, California, United States |
|
|
|
|